Institutional
Atlas Venture Associates IX, LLC
CIK 0001671207
$11.8M
Reported AUM
6
Positions
Q3 2023
Period
2023-11-13
Filed
Editorial summary
Summary for Atlas Venture Associates IX, LLC · Q3 2023 is not yet generated. It will appear here after the next nightly run.
Portfolio · Q3 2023
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | SKILLZ INC | — | — | — | — | $5.8M | 49.69% | — | HELD |
| 2 | CHRS | COHERUS BIOSCIENCES INC | $1.41 | -4.08% | 60.59% | -91.18% | $2.1M | 18.08% | — | HELD |
| 3 | SPRO | SPERO THERAPEUTICS INC | $1.17 | -2.50% | -49.13% | -93.92% | $1.6M | 13.93% | — | HELD |
| 4 | SNAP | SNAP INC | $4.69 | 0.00% | -48.18% | -93.84% | $1.3M | 11.38% | — | HELD |
| 5 | SYBX | SYNLOGIC INC | $1.20 | 4.35% | -18.92% | -97.01% | $497K | 4.23% | — | HELD |
| 6 | NTLA | INTELLIA THERAPEUTICS INC | $10.68 | -3.70% | -7.05% | -93.35% | $316K | 2.69% | — | HELD |
Source: SEC EDGAR · accession 0001104659-23-116913. 13F discloses long positions only — shorts, foreign equities, and options are excluded.